Coexpression cluster:C1986: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 11:56, 17 September 2013
Full id: C1986_Preadipocyte_Mesenchymal_basal_Fibroblast_Ewing_hepatic_Adipocyte
Phase1 CAGE Peaks
Hg19::chr7:134464377..134464413,+ | p1@CALD1 |
Hg19::chr7:134464414..134464425,+ | p6@CALD1 |
Hg19::chr7:134464465..134464476,+ | p7@CALD1 |
Hg19::chr7:134655216..134655252,+ | p42@CALD1 |
Hg19::chr7:41740181..41740234,- | p3@INHBA |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0048180 | activin complex | 0.00274327425429597 |
GO:0043509 | activin A complex | 0.00274327425429597 |
GO:0043511 | inhibin complex | 0.00274327425429597 |
GO:0043512 | inhibin A complex | 0.00274327425429597 |
GO:0045077 | negative regulation of interferon-gamma biosynthetic process | 0.00274327425429597 |
GO:0045650 | negative regulation of macrophage differentiation | 0.00274327425429597 |
GO:0032278 | positive regulation of gonadotropin secretion | 0.00274327425429597 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 0.00274327425429597 |
GO:0045578 | negative regulation of B cell differentiation | 0.00274327425429597 |
GO:0032276 | regulation of gonadotropin secretion | 0.00274327425429597 |
GO:0046880 | regulation of follicle-stimulating hormone secretion | 0.00274327425429597 |
GO:0046887 | positive regulation of hormone secretion | 0.00274327425429597 |
GO:0048184 | follistatin binding | 0.00274327425429597 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 0.00274327425429597 |
GO:0042541 | hemoglobin biosynthetic process | 0.00274327425429597 |
GO:0045620 | negative regulation of lymphocyte differentiation | 0.00274327425429597 |
GO:0032277 | negative regulation of gonadotropin secretion | 0.00274327425429597 |
GO:0017106 | activin inhibitor activity | 0.00274327425429597 |
GO:0032925 | regulation of activin receptor signaling pathway | 0.00274327425429597 |
GO:0045649 | regulation of macrophage differentiation | 0.00274327425429597 |
GO:0032274 | gonadotropin secretion | 0.00274327425429597 |
GO:0020027 | hemoglobin metabolic process | 0.00274327425429597 |
GO:0032924 | activin receptor signaling pathway | 0.00274327425429597 |
GO:0046884 | follicle-stimulating hormone secretion | 0.00274327425429597 |
GO:0045648 | positive regulation of erythrocyte differentiation | 0.00274327425429597 |
GO:0050869 | negative regulation of B cell activation | 0.00316526985601304 |
GO:0045577 | regulation of B cell differentiation | 0.0039187901672028 |
GO:0017022 | myosin binding | 0.0039187901672028 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 0.00425655424855442 |
GO:0030225 | macrophage differentiation | 0.00457171996631325 |
GO:0005160 | transforming growth factor beta receptor binding | 0.00457171996631325 |
GO:0046888 | negative regulation of hormone secretion | 0.00457171996631325 |
GO:0045646 | regulation of erythrocyte differentiation | 0.00457171996631325 |
GO:0045072 | regulation of interferon-gamma biosynthetic process | 0.00469189024750552 |
GO:0042326 | negative regulation of phosphorylation | 0.00469189024750552 |
GO:0045639 | positive regulation of myeloid cell differentiation | 0.00469189024750552 |
GO:0042095 | interferon-gamma biosynthetic process | 0.00469189024750552 |
GO:0045936 | negative regulation of phosphate metabolic process | 0.00469189024750552 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 0.00527475089124858 |
GO:0045619 | regulation of lymphocyte differentiation | 0.00535186357924799 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 0.00535186357924799 |
GO:0051048 | negative regulation of secretion | 0.00548549865239052 |
GO:0001541 | ovarian follicle development | 0.00548549865239052 |
GO:0032609 | interferon-gamma production | 0.00548549865239052 |
GO:0045638 | negative regulation of myeloid cell differentiation | 0.00548549865239052 |
GO:0046883 | regulation of hormone secretion | 0.00554377340373417 |
GO:0051250 | negative regulation of lymphocyte activation | 0.00554377340373417 |
GO:0051047 | positive regulation of secretion | 0.00587706040487411 |
GO:0005523 | tropomyosin binding | 0.00587706040487411 |
GO:0022601 | menstrual cycle phase | 0.00658201692404939 |
GO:0022602 | menstrual cycle process | 0.00659246796298695 |
GO:0050864 | regulation of B cell activation | 0.00659246796298695 |
GO:0008585 | female gonad development | 0.0069853226122356 |
GO:0030183 | B cell differentiation | 0.00710061156532613 |
GO:0046545 | development of primary female sexual characteristics | 0.00710061156532613 |
GO:0046660 | female sex differentiation | 0.00710061156532613 |
GO:0002573 | myeloid leukocyte differentiation | 0.0072164862557348 |
GO:0030218 | erythrocyte differentiation | 0.00751867023133696 |
GO:0042698 | menstrual cycle | 0.00751867023133696 |
GO:0045637 | regulation of myeloid cell differentiation | 0.00751867023133696 |
GO:0000082 | G1/S transition of mitotic cell cycle | 0.00751867023133696 |
GO:0046879 | hormone secretion | 0.00751867023133696 |
GO:0017148 | negative regulation of translation | 0.00892179721406047 |
GO:0031327 | negative regulation of cellular biosynthetic process | 0.00963864524147757 |
GO:0045597 | positive regulation of cell differentiation | 0.00991186012605939 |
GO:0009890 | negative regulation of biosynthetic process | 0.0104817334367983 |
GO:0008406 | gonad development | 0.0104817334367983 |
GO:0048608 | reproductive structure development | 0.0104817334367983 |
GO:0030308 | negative regulation of cell growth | 0.0105283196439338 |
GO:0045792 | negative regulation of cell size | 0.010573569048139 |
GO:0051046 | regulation of secretion | 0.0108572593869365 |
GO:0045137 | development of primary sexual characteristics | 0.0108572593869365 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.0108572593869365 |
GO:0048609 | reproductive process in a multicellular organism | 0.0108572593869365 |
GO:0032504 | multicellular organism reproduction | 0.0108572593869365 |
GO:0042113 | B cell activation | 0.0108572593869365 |
GO:0045926 | negative regulation of growth | 0.0108572593869365 |
GO:0042325 | regulation of phosphorylation | 0.0111023468893183 |
GO:0030098 | lymphocyte differentiation | 0.0111023468893183 |
GO:0045596 | negative regulation of cell differentiation | 0.0111239770299129 |
GO:0042089 | cytokine biosynthetic process | 0.0111239770299129 |
GO:0042107 | cytokine metabolic process | 0.0111239770299129 |
GO:0051094 | positive regulation of developmental process | 0.0111239770299129 |
GO:0051174 | regulation of phosphorus metabolic process | 0.0111239770299129 |
GO:0019220 | regulation of phosphate metabolic process | 0.0111239770299129 |
GO:0003001 | generation of a signal involved in cell-cell signaling | 0.0111538065677599 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 0.0117226808852989 |
GO:0051249 | regulation of lymphocyte activation | 0.0117226808852989 |
GO:0030099 | myeloid cell differentiation | 0.0117226808852989 |
GO:0051093 | negative regulation of developmental process | 0.0117226808852989 |
GO:0050865 | regulation of cell activation | 0.0120450365843769 |
GO:0007548 | sex differentiation | 0.0120628609213449 |
GO:0051329 | interphase of mitotic cell cycle | 0.012521706120398 |
GO:0003006 | reproductive developmental process | 0.0126796167943465 |
GO:0002521 | leukocyte differentiation | 0.0128430095254642 |
GO:0051325 | interphase | 0.0128430095254642 |
GO:0007050 | cell cycle arrest | 0.0142618136123162 |
GO:0051248 | negative regulation of protein metabolic process | 0.0145349377240317 |
GO:0001816 | cytokine production | 0.0156311719386937 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 0.019028151025804 |
GO:0005516 | calmodulin binding | 0.0191102653726784 |
GO:0045595 | regulation of cell differentiation | 0.019324669846072 |
GO:0046649 | lymphocyte activation | 0.0205955677522962 |
GO:0030097 | hemopoiesis | 0.0211016001926894 |
GO:0001558 | regulation of cell growth | 0.0211016001926894 |
GO:0003012 | muscle system process | 0.0211016001926894 |
GO:0006936 | muscle contraction | 0.0211016001926894 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.0219172624202018 |
GO:0045321 | leukocyte activation | 0.0225925424131273 |
GO:0002520 | immune system development | 0.0226352337476506 |
GO:0006417 | regulation of translation | 0.0226771413179177 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0241143574865719 |
GO:0016049 | cell growth | 0.0241143574865719 |
GO:0040008 | regulation of growth | 0.0241143574865719 |
GO:0008361 | regulation of cell size | 0.0243210210561916 |
GO:0001501 | skeletal development | 0.0243210210561916 |
GO:0001775 | cell activation | 0.0243210210561916 |
GO:0006917 | induction of apoptosis | 0.0243210210561916 |
GO:0012502 | induction of programmed cell death | 0.0243210210561916 |
GO:0032501 | multicellular organismal process | 0.0243210210561916 |
GO:0005179 | hormone activity | 0.0243210210561916 |
GO:0009889 | regulation of biosynthetic process | 0.0243210210561916 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.0247880963368237 |
GO:0045786 | negative regulation of progression through cell cycle | 0.0248079815534451 |
GO:0050793 | regulation of developmental process | 0.0258084567133596 |
GO:0008083 | growth factor activity | 0.0274410651209666 |
GO:0043065 | positive regulation of apoptosis | 0.0275441036420166 |
GO:0043068 | positive regulation of programmed cell death | 0.0275441036420166 |
GO:0051239 | regulation of multicellular organismal process | 0.0293187191323811 |
GO:0045941 | positive regulation of transcription | 0.0293187191323811 |
GO:0045935 | positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0301332864785564 |
GO:0051179 | localization | 0.0307047454263562 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 0.0308048393720118 |
GO:0022414 | reproductive process | 0.0310822373624248 |
GO:0005125 | cytokine activity | 0.0313554509768971 |
GO:0000278 | mitotic cell cycle | 0.0327235991619901 |
GO:0000074 | regulation of progression through cell cycle | 0.0351611490324562 |
GO:0051726 | regulation of cell cycle | 0.0354965159760112 |
GO:0042802 | identical protein binding | 0.0355710461104435 |
GO:0031325 | positive regulation of cellular metabolic process | 0.0355710461104435 |
GO:0022403 | cell cycle phase | 0.0357037107339966 |
GO:0031324 | negative regulation of cellular metabolic process | 0.036122093213212 |
GO:0006928 | cell motility | 0.036122093213212 |
GO:0051674 | localization of cell | 0.036122093213212 |
GO:0046903 | secretion | 0.036122093213212 |
GO:0009893 | positive regulation of metabolic process | 0.0365248623183854 |
GO:0051246 | regulation of protein metabolic process | 0.0389616696652158 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 0.0389616696652158 |
GO:0009892 | negative regulation of metabolic process | 0.0397965356152556 |
GO:0003779 | actin binding | 0.0397965356152556 |
GO:0000902 | cell morphogenesis | 0.0428340666047415 |
GO:0032989 | cellular structure morphogenesis | 0.0428340666047415 |
GO:0005615 | extracellular space | 0.0469705347814123 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
fibroblast | 3.24e-16 | 76 |
non-terminally differentiated cell | 1.10e-14 | 106 |
muscle precursor cell | 3.43e-11 | 58 |
myoblast | 3.43e-11 | 58 |
multi-potent skeletal muscle stem cell | 3.43e-11 | 58 |
electrically responsive cell | 3.53e-11 | 61 |
electrically active cell | 3.53e-11 | 61 |
muscle cell | 8.01e-11 | 55 |
mesodermal cell | 8.38e-11 | 121 |
smooth muscle cell | 3.35e-10 | 43 |
smooth muscle myoblast | 3.35e-10 | 43 |
contractile cell | 6.80e-10 | 59 |
vascular associated smooth muscle cell | 1.04e-09 | 32 |
embryonic cell | 1.24e-09 | 250 |
skin fibroblast | 1.28e-07 | 23 |
preadipocyte | 9.18e-07 | 12 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.00991994 |
MA0004.1 | 0.626788 |
MA0006.1 | 0.452993 |
MA0007.1 | 0.606704 |
MA0009.1 | 1.11255 |
MA0014.1 | 0.369468 |
MA0017.1 | 0.496101 |
MA0019.1 | 0.784036 |
MA0024.1 | 1.00439 |
MA0025.1 | 1.24931 |
MA0027.1 | 2.73598 |
MA0028.1 | 0.470679 |
MA0029.1 | 1.02437 |
MA0030.1 | 1.01252 |
MA0031.1 | 3.57633 |
MA0038.1 | 0.736268 |
MA0040.1 | 1.03042 |
MA0041.1 | 0.64667 |
MA0042.1 | 0.612397 |
MA0043.1 | 1.11288 |
MA0046.1 | 1.10134 |
MA0048.1 | 0.195817 |
MA0050.1 | 0.613347 |
MA0051.1 | 0.731787 |
MA0052.1 | 1.03442 |
MA0055.1 | 0.0853006 |
MA0056.1 | 0 |
MA0057.1 | 0.554727 |
MA0058.1 | 0.523638 |
MA0059.1 | 0.522232 |
MA0060.1 | 1.55172 |
MA0061.1 | 0.291022 |
MA0063.1 | 0 |
MA0066.1 | 0.736721 |
MA0067.1 | 1.43651 |
MA0068.1 | 0.247962 |
MA0069.1 | 1.09737 |
MA0070.1 | 1.08584 |
MA0071.1 | 0.695094 |
MA0072.1 | 1.0812 |
MA0073.1 | 0.00220137 |
MA0074.1 | 0.730989 |
MA0076.1 | 0.540943 |
MA0077.1 | 1.07324 |
MA0078.1 | 1.95181 |
MA0081.1 | 0.522409 |
MA0083.1 | 1.12028 |
MA0084.1 | 1.62584 |
MA0087.1 | 1.07867 |
MA0088.1 | 1.3271 |
MA0089.1 | 0 |
MA0090.1 | 0.556637 |
MA0091.1 | 0.629594 |
MA0092.1 | 1.43794 |
MA0093.1 | 0.456342 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.750974 |
MA0101.1 | 0.459973 |
MA0103.1 | 0.442769 |
MA0105.1 | 0.175503 |
MA0106.1 | 0.779931 |
MA0107.1 | 0.378225 |
MA0108.2 | 0.94238 |
MA0109.1 | 0 |
MA0111.1 | 0.5713 |
MA0113.1 | 0.797251 |
MA0114.1 | 0.372523 |
MA0115.1 | 1.35895 |
MA0116.1 | 0.994489 |
MA0117.1 | 1.1512 |
MA0119.1 | 0.504689 |
MA0122.1 | 1.17777 |
MA0124.1 | 1.31673 |
MA0125.1 | 1.23103 |
MA0130.1 | 0 |
MA0131.1 | 0.855546 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.14377 |
MA0136.1 | 0.743749 |
MA0139.1 | 0.277033 |
MA0140.1 | 0.692258 |
MA0141.1 | 0.520334 |
MA0142.1 | 0.912455 |
MA0143.1 | 0.797437 |
MA0144.1 | 0.356507 |
MA0145.1 | 0.143698 |
MA0146.1 | 0.0359558 |
MA0147.1 | 0.386018 |
MA0148.1 | 1.57313 |
MA0149.1 | 3.99004 |
MA0062.2 | 0.284987 |
MA0035.2 | 0.691506 |
MA0039.2 | 0.311551 |
MA0138.2 | 0.837782 |
MA0002.2 | 0.30855 |
MA0137.2 | 1.20193 |
MA0104.2 | 0.320919 |
MA0047.2 | 1.80892 |
MA0112.2 | 0.136971 |
MA0065.2 | 0.146576 |
MA0150.1 | 0.550239 |
MA0151.1 | 0 |
MA0152.1 | 0.69926 |
MA0153.1 | 1.21379 |
MA0154.1 | 0.172764 |
MA0155.1 | 0.130813 |
MA0156.1 | 1.20729 |
MA0157.1 | 2.04894 |
MA0158.1 | 0 |
MA0159.1 | 0.386729 |
MA0160.1 | 0.669748 |
MA0161.1 | 0 |
MA0162.1 | 0.0592265 |
MA0163.1 | 0.0439995 |
MA0164.1 | 0.810347 |
MA0080.2 | 0.456437 |
MA0018.2 | 0.781393 |
MA0099.2 | 0.699641 |
MA0079.2 | 0.340387 |
MA0102.2 | 1.66336 |
MA0258.1 | 0.345771 |
MA0259.1 | 0.395396 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
FOS#2353 | 3 | 5.39877318533664 | 0.0115389531727874 | 0.0421974414514776 |
FOXA1#3169 | 3 | 6.64885184963127 | 0.00638902516656872 | 0.0278107531101267 |
FOXA2#3170 | 3 | 14.7782782515991 | 0.000628919285119448 | 0.00517479722828252 |
GTF2F1#2962 | 3 | 7.64379652605459 | 0.0042841549641205 | 0.0203489567171994 |
JUN#3725 | 3 | 7.5076975154018 | 0.00451120655290603 | 0.0213390960269465 |
MXI1#4601 | 3 | 5.97694297725558 | 0.00865300488936688 | 0.0329569008293128 |
NR3C1#2908 | 3 | 8.98381399870382 | 0.00268799578894045 | 0.0147994934999817 |
RFX5#5993 | 3 | 7.22874649631706 | 0.0050291827895866 | 0.0234703436865648 |
SRF#6722 | 3 | 8.27830695730069 | 0.00340484607377615 | 0.0173640665608236 |
STAT3#6774 | 3 | 6.31167899829254 | 0.00741117212246054 | 0.0306164868991597 |
TAF7#6879 | 3 | 6.85984164295435 | 0.00584328640701904 | 0.0262525591096387 |
TRIM28#10155 | 3 | 11.1543150271575 | 0.00143315927152925 | 0.0092030079414193 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.